Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VCAM1 Antikörper (FITC)

VCAM1 Reaktivität: Human FACS, ICC Wirt: Maus Monoclonal B-K9 FITC
Produktnummer ABIN6253936
  • Target Alle VCAM1 Antikörper anzeigen
    VCAM1 (Vascular Cell Adhesion Molecule 1 (VCAM1))
    Reaktivität
    • 136
    • 101
    • 56
    • 25
    • 15
    • 8
    • 8
    • 4
    • 3
    • 1
    Human
    Wirt
    • 94
    • 74
    • 39
    • 5
    • 1
    • 1
    Maus
    Klonalität
    • 120
    • 92
    • 1
    Monoklonal
    Konjugat
    • 94
    • 25
    • 24
    • 11
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VCAM1 Antikörper ist konjugiert mit FITC
    Applikation
    • 113
    • 101
    • 52
    • 44
    • 36
    • 29
    • 27
    • 26
    • 23
    • 16
    • 14
    • 11
    • 8
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Spezifität
    B-K9 produces mouse IgG1 immunoglobulins directed against a 110 kD protein known as human CD106. It reacts with approximately 15% of peripheral lymphocytes and between 30-90% activated HUVEC
    Klon
    B-K9
    Isotyp
    IgG1
    Top Product
    Discover our top product VCAM1 Primärantikörper
  • Applikationshinweise
    tochemistry on cytospots,  immunohistochemistry on frozen tissue sections
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Lagerung
    4 °C
  • Target
    VCAM1 (Vascular Cell Adhesion Molecule 1 (VCAM1))
    Andere Bezeichnung
    CD106 (VCAM1 Produkte)
    Synonyme
    CD106 antikoerper, INCAM-100 antikoerper, Vcam-1 antikoerper, VCAM1B antikoerper, fi76d06 antikoerper, wu:fi76d06 antikoerper, zgc:158875 antikoerper, VCAM1 antikoerper, vascular cell adhesion molecule 1 antikoerper, vascular cell adhesion molecule 1b antikoerper, VCAM1 antikoerper, Vcam1 antikoerper, vcam1b antikoerper, VCAM-1 antikoerper
    Hintergrund
    Antigen distribution: CD106 antigen binds the integrins a4b1 (CD49d/CD29, VLA-4) and a4b7 [4]. VLA-4 is the dominant ligand in cells expressing both integrins. Endothelial CD106 contributes to the extravasation of lymphocytes, monocytes, basophils and eosinophils (but not neutrophils) from blood vessels, especially at sites of inflammation. The VLA-4 interaction can mediate both the initial tethering and rolling of lymphocytes on endothelium as well as their subsequent arrest and firm adhesion [5]. CD106 expression on non-vascular tissues is thought to play a role in the interaction of hematopoietic progenitors with bone marrow stromal cells, B cell binding to follicular dendritic cells, co-stimulation of T cells and embryonic development [1,2,3]. Cellular Expression: VCAM-1. Vascular endothelium, dendritic cells, macrophages
    Pathways
    Carbohydrate Homeostasis
Sie sind hier:
Kundenservice